The Centre for Genomic Medicine aims to use genomics and epigenomics to understand the mechanisms underpinning degenerative disease to advance patient care through improved prediction, prevention and treatment. A major effort is being made toward the recruitment and training of the brightest young scientists and clinicians to make a difference to healthy ageing.
Researchers at The Centre of Genomic Medicine exploit state of the art technologies to understand how genomic and epigenomic variants influence molecular and cellular pathways and control physiological function to improve our understanding of health and disease. Expertise within the group also focuses on the formulation and manufacture of personalised medicines to harness the power of genomic medicine, accelerating discovery genomic research towards clinical application.
Across the group we have expertise in applying genomic medicine to a range of major diseases including cardiovascular epigenomics of hypertension and cardiometabolic disease. Genomic approaches are also being used to investigate underlying mechanisms of prostate and brain cancer in addition to degenerative eye disease e.g. glaucoma and corneal dystrophy.